“Having an oral formulation of semaglutide in addition to the subcutaneous [...] formula available will allow people who struggle to lose weight with diet and physical activity alone to take ...

Thank you for attending today’s Beachbody Company Inc., Fourth Quarter 2024 Earnings Conference Call. My name is Tania, and I will be your moderator for today’s call. All lines will be muted during ...

Peptides are gaining traction for everything from the potential of muscle recovery to brain support—but as they show up in ...

She may be known for her comedy, butAmy Schumer showed a more vulnerable side as she became candid about her weight loss ...

Amy Schumer has shared another honest update on her health journey. The Trainwreck star recently revealed she is now seeing positive results from new treatments after previously suffering severe side ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time ...

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ...

The large-scale study focused on use of semaglutide and non-GLP-1 RAs. An increased risk for nonarteritic anterior ischemic optic neuropathy with semaglutide was seen at 2, 3 and 4 years from the ...

Oral semaglutide reduced major cardiovascular events by 14% in patients with type 2 diabetes over nearly 4 years. The trial involved 9650 patients with type 2 diabetes and cardiovascular or kidney ...

The use of semaglutide in patients with diabetes was associated with a significantly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with those taking drugs for ...